{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:10:23Z","timestamp":1788246623025,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011476","name":"Southwest Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012397","name":"Army Medical University","doi-asserted-by":"publisher","award":["XZ-2019-505-073"],"award-info":[{"award-number":["XZ-2019-505-073"]}],"id":[{"id":"10.13039\/501100012397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.intimp.2020.106823","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T05:43:31Z","timestamp":1597124611000},"page":"106823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Chebulanin exerts its anti-inflammatory and anti-arthritic effects via inhibiting NF-\u03baB and MAPK activation in collagen-induced arthritis mice"],"prefix":"10.1016","volume":"88","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangbi","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2020.106823_b0005","doi-asserted-by":"crossref","first-page":"ITC1-ITC16","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid Arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"10055","key":"10.1016\/j.intimp.2020.106823_b0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.intimp.2020.106823_b0015","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2020.106823_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/annrheumdis-2019-216758","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.106823_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA TREATMENT RECOMMENDATIONS","volume":"68","author":"Singh","year":"2016","journal-title":"Arthrit. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106823_b0030","first-page":"501","article-title":"Rheumatoid Arthritis: A Brief Overview of the Treatment, Medical principles and practice : international journal of the Kuwait University","volume":"27","author":"Bullock","year":"2018","journal-title":"Health Sci. Centre"},{"issue":"7","key":"10.1016\/j.intimp.2020.106823_b0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.101142","article-title":"Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry","volume":"38","author":"Markenson","year":"2011","journal-title":"J. Rheumatol."},{"issue":"9990","key":"10.1016\/j.intimp.2020.106823_b0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.106823_b0045","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.160941","article-title":"The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate","author":"Stevenson","year":"2017","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106823_b0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cyto.2015.08.260","article-title":"The role of cytokines in the pathogenesis of rheumatoid arthritis\u2013Practical and potential application of cytokines as biomarkers and targets of personalized therapy","volume":"76","author":"Brzustewicz","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2020.106823_b0055","article-title":"Cytokine targeting in rheumatoid arthritis","author":"Bui","year":"2018","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106823_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020015","article-title":"Roles of NF-kappaB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches","volume":"5","author":"Park","year":"2016","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2020.106823_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2017.08.021","article-title":"MicroRNAs and bioactive compounds on TLR\/MAPK signaling in rheumatoid arthritis","volume":"473","author":"Sujitha","year":"2017","journal-title":"Clin. Chim. Acta Int. J Clin. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2020.106823_b0070","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/art.38327","article-title":"Alternative p38 MAPKs are essential for collagen-induced arthritis","volume":"66","author":"Criado","year":"2014","journal-title":"Arthrit. Rheumatol."},{"key":"10.1016\/j.intimp.2020.106823_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jep.2015.10.010","article-title":"The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms","volume":"176","author":"Lu","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106823_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/nu9010070","article-title":"Phytomedicine in Joint Disorders","volume":"9","author":"Dragos","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2020.106823_b0085","article-title":"The development of Terminalia chebula Retz. (Combretaceae) in clinical research","volume":"03","author":"Anwesa","year":"2013","journal-title":"Aptb"},{"key":"10.1016\/j.intimp.2020.106823_b0090","doi-asserted-by":"crossref","unstructured":"A. Hedina, P. Kotti, J. Kausar, Sivasamy, V. Anand, Phytopharmacological overview of terminalia chebula retz, Pharmacognosy Journal 8(4) (2016) 307-309.","DOI":"10.5530\/pj.2016.4.1"},{"issue":"2","key":"10.1016\/j.intimp.2020.106823_b0095","first-page":"61","article-title":"Phytochemical and pharmacological actions of triphala: Ayurvedic formulation - A review","volume":"15","author":"Gowda","year":"2012","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"issue":"8","key":"10.1016\/j.intimp.2020.106823_b0100","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/cbdv.201300149","article-title":"Biological Activities of Phenolic Compounds and Triterpenoids from the Galls of Terminalia chebula","volume":"10","author":"Manosroi","year":"2013","journal-title":"Chem. Biodivers."},{"issue":"22","key":"10.1016\/j.intimp.2020.106823_b0105","first-page":"2238","article-title":"Mechanism of Tibetan medicine Terminalia Chebula Retz in rheumatoid arthritis:a study based on network pharmacology","volume":"41","author":"Fang","year":"2019","journal-title":"Acta Acad. Med. Militaris Tertiae"},{"issue":"9","key":"10.1016\/j.intimp.2020.106823_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139052","article-title":"Anti-Arthritic Effect of Chebulanin on Collagen-Induced Arthritis in Mice","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.intimp.2020.106823_b0115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2020.106823_b0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.intimp.2019.04.027","article-title":"Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects","volume":"72","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106823_b0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2017.12.011","article-title":"Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway","volume":"55","author":"Pan","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106823_b0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00281-017-0622-4","article-title":"Arthritis models: usefulness and interpretation","volume":"39","author":"Bessis","year":"2017","journal-title":"Seminars Immunopathol."},{"key":"10.1016\/j.intimp.2020.106823_b0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejphar.2015.03.047","article-title":"Animal models of rheumatoid arthritis: How informative are they?","volume":"759","author":"McNamee","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2020.106823_b0140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0300985815588612","article-title":"Mouse Models of Rheumatoid Arthritis","volume":"52","author":"Caplazi","year":"2015","journal-title":"Vet. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106823_b0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/art.1780290114","article-title":"Homologous type II collagen induces chronic and progressive arthritis in mice","volume":"29","author":"Holmdahl","year":"1986","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2020.106823_b0150","first-page":"639","article-title":"Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA\/1 mice with heterologous and autologous collagen II","volume":"62","author":"Holmdahl","year":"1985","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.106823_b0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/art.1780291212","article-title":"Female sex hormones suppress development of collagen-induced arthritis in mice","volume":"29","author":"Holmdahl","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.106823_b0160","doi-asserted-by":"crossref","unstructured":"Leflunomide for rheumatoid arthritis, Drug and therapeutics bulletin 38(7) (2000) 52-4.","DOI":"10.1136\/dtb.2000.38752"},{"issue":"6","key":"10.1016\/j.intimp.2020.106823_b0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/39.6.655","article-title":"A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis","volume":"39","author":"Emery","year":"2000","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2020.106823_b0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","article-title":"When and where does inflammation begin in rheumatoid arthritis?","volume":"26","author":"Demoruelle","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106823_b0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13105-012-0216-5","article-title":"Inflammation and rheumatoid arthritis","volume":"69","author":"Shrivastava","year":"2013","journal-title":"J. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.intimp.2020.106823_b0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"New England J. Med."},{"issue":"10","key":"10.1016\/j.intimp.2020.106823_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells7100161","article-title":"Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development","volume":"7","author":"Yap","year":"2018","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.intimp.2020.106823_b0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","article-title":"Selected cytokine pathways in rheumatoid arthritis","volume":"39","author":"Noack","year":"2017","journal-title":"Seminars Immunopathol."},{"key":"10.1016\/j.intimp.2020.106823_b0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.intimp.2015.11.030","article-title":"MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-kappaB","volume":"30","author":"Zhang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106823_b0200","doi-asserted-by":"crossref","first-page":"5790291","DOI":"10.1155\/2019\/5790291","article-title":"Flemingia philippinensis Flavonoids Relieve Bone Erosion and Inflammatory Mediators in CIA Mice by Downregulating NF-kappaB and MAPK Pathways","volume":"2019","author":"Sun","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2020.106823_b0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-kappaB and the Transcriptional Control of Inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106823_b0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1756-185X.12293","article-title":"Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis","volume":"17","author":"MacFarlane","year":"2014","journal-title":"Int. J. Rheumat. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2020.106823_b0215","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/jsfa.8664","article-title":"Anti-inflammatory effects of polyphenols in arthritis","volume":"98","author":"Oliviero","year":"2018","journal-title":"J. Sci. Food Agric."},{"issue":"8","key":"10.1016\/j.intimp.2020.106823_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081589","article-title":"Could Polyphenols Help in the Control of Rheumatoid Arthritis?","volume":"24","author":"Sung","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.intimp.2020.106823_b0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000445645","article-title":"Terminalia Chebulanin Attenuates Psoriatic Skin Lesion via Regulation of Heme Oxygenase-1","volume":"39","author":"An","year":"2016","journal-title":"Cell. Physiol. Biochem. Int. J. Experimental Cell. Physiol. Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106823_b0230","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ptr.3398","article-title":"Terminalia chebula Extract Acts as a Potential NF-kappa B Inhibitor in Human Lymphoblastic T Cells","volume":"25","author":"Das","year":"2011","journal-title":"Phytother Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920301806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920301806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:42:36Z","timestamp":1762551756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920301806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":46,"alternative-id":["S1567576920301806"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106823","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chebulanin exerts its anti-inflammatory and anti-arthritic effects via inhibiting NF-\u03baB and MAPK activation in collagen-induced arthritis mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106823"}}